Table 2:
Univariable | Multivariable | ||||
---|---|---|---|---|---|
Control/Case | Participants with a negative LDCT scan | Participants with a negative LDCT scan | |||
OR (95% C.I.) | P | OR (95% C.I.) | P* | ||
IL-6 | |||||
<25th Percentile | 103/42 | Reference | Reference | ||
25th – 50th Percentile | 103/58 | 1.38 (0.85–2.24) | 0.19 | 1.48 (0.87–2.53) | 0.15 |
50th – 75th Percentile | 103/73 | 1.74 (1.09–2.77) | 0.02 | 1.88 (1.11–3.21) | 0.02 |
>75th Percentile | 103/83 | 2.00 (1.26–3.16) | 0.003 | 2.82 (1.64–4.86) | <0.001 |
Trend | 1.40 (1.18–1.66) | 0.002 | 1.40 (1.18–1.66) | <0.001 | |
<Median | 206/100 | Reference | Reference | ||
>Median | 205/156 | 1.57 (1.14–2.15) | 0.005 | 1.84 (1.26–2.68) | 0.001 |
IL-8 | |||||
<25th Percentile | 105/50 | Reference | Reference | ||
25th – 50th Percentile | 104/69 | 1.40 (0.88–2.19) | 0.15 | 1.57 (0.95–2.60) | 0.08 |
50th – 75th Percentile | 105/52 | 1.04 (0.65–1.67) | 0.87 | 1.08 (0.63–1.86) | 0.77 |
>75th Percentile | 104/91 | 1.84 (1.18–2.85) | 0.007 | 2.25 (1.37–3.71) | 0.001 |
Trend | 1.18 (1.02–1.35) | 0.02 | 1.25 (1.06–1.46) | 0.006 | |
<Median | 209/119 | Reference | Reference | ||
>Median | 209/143 | 1.20 (0.88–1.63) | 0.25 | 1.30 (0.90–1.86) | 0.16 |
CRP | |||||
<25th Percentile | 105/50 | Reference | Reference | ||
25th – 50th Percentile | 104/69 | 1.57 (0.98–2.52) | 0.06 | 1.65 (0.96–2.83) | 0.07 |
50th – 75th Percentile | 105/52 | 1.81 (1.14–2.87) | 0.01 | 2.18 (1.28–3.71) | 0.004 |
>75th Percentile | 104/91 | 1.76 (1.11–2.80) | 0.02 | 2.46 (1.43–4.23) | 0.001 |
Trend | 1.19 (1.03–1.37) | 0.02 | 1.33 (1.13–1.58) | 0.001 | |
<Median | 209/119 | Reference | Reference | ||
>Median | 209/143 | 1.39 (1.02–1.90) | 0.04 | 1.73 (1.20–2.49) | 0.003 |
IFN-g | |||||
<25th Percentile | 104/50 | Reference | Reference | ||
25th – 50th Percentile | 103/57 | 1.15 (0.72–1.84) | 0.56 | 1.11 (0.65–1.87) | 0.72 |
50th – 75th Percentile | 104/64 | 1.28 (0.81–2.03) | 0.29 | 1.28 (0.76–2.13) | 0.35 |
>75th Percentile | 103/91 | 1.84 (1.18–2.85) | 0.007 | 1.89 (1.16–3.09) | 0.01 |
Trend | 1.22 (1.06–1.40) | 0.005 | 1.24 (1.06–1.45) | 0.007 | |
<Median | 207/107 | Reference | Reference | ||
>Median | 207/155 | 1.45 (1.06–1.98) | 0.02 | 1.50 (1.06–2.14) | 0.02 |
IL-12/IL-23p40 | |||||
<25th Percentile | 105/50 | Reference | Reference | ||
25th – 50th Percentile | 104/65 | 1.31 (0.83–2.07) | 0.24 | 1.25 (0.73–2.12) | 0.42 |
50th – 75th Percentile | 105/62 | 1.24 (0.78–1.97) | 0.36 | 1.59 (0.93–2.72) | 0.09 |
>75th Percentile | 104/85 | 1.72 (1.10–2.67) | 0.02 | 2.49 (1.46–4.23) | 0.001 |
Trend | 1.17 (1.02–1.35) | 0.03 | 1.36 (1.15–1.61) | 0.001 | |
<Median | 209/115 | Reference | Reference | ||
>Median | 209/147 | 1.27 (0.94–1.74) | 0.12 | 1.77 (1.22–2.57) | 0.002 |
P adjusted for age, gender, smoking status, pack-years of smoking, race, BMI, history of COPD, childhood asthma, adulthood asthma, asbestosis, chronic bronchitis, bronchiectasis, emphysema, fibrosis of the lung, pneumonia, sarcoidosis, silicosis, tuberculosis, diabetes, family history of lung cancer